Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CISS2: MSCs for Septic Shock
NCT03369275Phase 2Unknown
- Sponsor
- Ottawa Hospital Research Institute
- Start
- Mar 2018
- Primary completion
- Feb 2020
- Modality
- Mesenchymal Stem Cells
01
Overview
A Phase 2 trial of Provacel in septic shock, sponsored by Ottawa Hospital Research Institute. Status: unknown.
02
Drugs
Provacel
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT03369275.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03369275.